The DigitalHealth.il conference is proud to present the 6th annual DigitalHealth.il contest which recognizes outstanding achievements in health and wellness technologies.
The contest reaches out to companies demonstrating innovative technologies which will significantly improve the quality of future healthcare delivery.
Winners will be selected by an expert panel of judges and audience voting.
The final stage will take place live during the Digitalhealth.il conference on
April 22, 2020 at the Hilton TLV Hotel.
Companies that demonstrate innovative technologies which will significantly improve the quality of future healthcare delivery.
Applications, presentations and executive summaries will be assessed by our special screening committee headed by EY Israel.
Their selections will be based on the following criteria:
As part of the preparation process for the semi-final stage, companies will enjoy professional assistance and guidance.
Company representatives will take part in a presentation skills workshop designed and conducted by Barry Katz Ltd. to help them create and present the perfect pitch. Companies’ participation is mandatory.
Our pitch preparation process allows our semi-finalists to take part in unique presentation workshops and one-on-one meetings with industry leaders. Our goal is to help them prepare for the semi-final event which includes a live presentation in front of an audience of investors and c-level professionals from the industry. Those selected will then receive additional workshops and personal guidance in preparation for their “PITCH perfect” moment at the finals in January.
The guidance process will be led by Barry Katz Ltd. The Barry Katz team believes that no one will recognize a good idea unless it is well presented.
Great ideas do not sell themselves. The presenter has to pitch an idea in a way that instantly grabs and keeps audiences’ attention. This can be best achieved with an authentic and unique style, with a simple easy to understand, clear and credible value statement.
Head of Samsung Strategy and Innovation Center, Israel,
Samsung Catalyst Fund
Head of Innovation & CX, Takeda
CEO, Sanara Ventures
Global Service Partner, Life Sciences Sector Leader, EY Israel
Head of Government Affairs Corporate and International Markets, Teva Pharm
Head of Investments,
Managing General Partner,
Managing Partner, Qure Ventures
Global Innovation Lead,
Pfizer Digital Innovation Lab
Managing Director, OrbiMed
Director, IBM Research
Managing General Partner,
Tel Aviv Venture Partners
Samsung NEXT Ventures
Eyal is EY Israel’s Life Sciences Sector Leader based in Tel Aviv, Israel. He has over 20 years of national and global experience serving Growth and Life Sciences clients.
Eyal holds a BA in Accounting from Tel Aviv Management College. He is a Certified Public accountant in Israel. Eyal has been serving as Teva Pharmaceuticals Global Client Service Partner for the last 8 years, leading EY global activities and relationships.
Eyal has served clients in every stage of growth and helped many companies from the early stage through the challenges of launching initial products and establishing a market leader position. Eyal has provided consulting to various Growth and Life Sciences companies on planning strategy, acquisitions, divestitures, due diligence, and post-merger integrations.
He has worked on hundreds of public and private financing, including over 40 IPOs and follow-on offerings.
Eyal’s professional experience includes corporate alliances, spinouts, joint ventures and mergers & acquisitions.